314 related articles for article (PubMed ID: 30451720)
1. Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor.
Dale DC; Bolyard AA; Marrero T; Kelley ML; Makaryan V; Tran E; Leung J; Boxer LA; Kishnani PS; Austin S; Wanner C; Ferrecchia IA; Khalaf D; Maze D; Kurtzberg J; Zeidler C; Welte K; Weinstein DA
Curr Opin Hematol; 2019 Jan; 26(1):16-21. PubMed ID: 30451720
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type 1b.
Calderwood S; Kilpatrick L; Douglas SD; Freedman M; Smith-Whitley K; Rolland M; Kurtzberg J
Blood; 2001 Jan; 97(2):376-82. PubMed ID: 11154211
[TBL] [Abstract][Full Text] [Related]
4. Improvement of neutropenia and neutrophil dysfunction by granulocyte colony-stimulating factor in a patient with glycogen storage disease type Ib.
Ishiguro A; Nakahata T; Shimbo T; Amano Y; Yasui K; Koike K; Komiyama A
Eur J Pediatr; 1993 Jan; 152(1):18-20. PubMed ID: 7680314
[TBL] [Abstract][Full Text] [Related]
5. Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using
Turki A; Stockler S; Sirrs S; Duddy K; Ho G; Elango R
Mol Genet Metab Rep; 2023 Mar; 34():100955. PubMed ID: 36632325
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire.
Grünert SC; Derks TGJ; Adrian K; Al-Thihli K; Ballhausen D; Bidiuk J; Bordugo A; Boyer M; Bratkovic D; Brunner-Krainz M; Burlina A; Chakrapani A; Corpeleijn W; Cozens A; Dawson C; Dhamko H; Milosevic MD; Eiroa H; Finezilber Y; Moura de Souza CF; Garcia-Jiménez MC; Gasperini S; Haas D; Häberle J; Halligan R; Fung LH; Hörbe-Blindt A; Horka LM; Huemer M; Uçar SK; Kecman B; Kilavuz S; Kriván G; Lindner M; Lüsebrink N; Makrilakis K; Mei-Kwun Kwok A; Maier EM; Maiorana A; McCandless SE; Mitchell JJ; Mizumoto H; Mundy H; Ochoa C; Pierce K; Fraile PQ; Regier D; Rossi A; Santer R; Schuman HC; Sobieraj P; Spenger J; Spiegel R; Stepien KM; Tal G; Tanšek MZ; Torkar AD; Tchan M; Thyagu S; Schrier Vergano SA; Vucko E; Weinhold N; Zsidegh P; Wortmann SB
Genet Med; 2022 Aug; 24(8):1781-1788. PubMed ID: 35503103
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib.
Schroten H; Roesler J; Breidenbach T; Wendel U; Elsner J; Schweitzer S; Zeidler C; Burdach S; Lohmann-Matthes ML; Wahn V
J Pediatr; 1991 Nov; 119(5):748-54. PubMed ID: 1719175
[TBL] [Abstract][Full Text] [Related]
8. Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.
Wortmann SB; Van Hove JLK; Derks TGJ; Chevalier N; Knight V; Koller A; Oussoren E; Mayr JA; van Spronsen FJ; Lagler FB; Gaughan S; Van Schaftingen E; Veiga-da-Cunha M
Blood; 2020 Aug; 136(9):1033-1043. PubMed ID: 32294159
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1b.
Lesma E; Riva E; Giovannini M; Di Giulio AM; Gorio A
Int J Immunopathol Pharmacol; 2005; 18(2):297-307. PubMed ID: 15888252
[TBL] [Abstract][Full Text] [Related]
10. Prolonged granulocyte colony stimulating factor use in glycogen storage disease type 1b associated with acute myeloid leukemia and with shortened telomere length.
Li AM; Thyagu S; Maze D; Schreiber R; Sirrs S; Stockler-Ipsiroglu S; Sutherland H; Vercauteren S; Schultz KR
Pediatr Hematol Oncol; 2018 Feb; 35(1):45-51. PubMed ID: 29652549
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor in glycogen storage disease type 1b. Results of the European Study on Glycogen Storage Disease Type 1.
Visser G; Rake JP; Labrune P; Leonard JV; Moses S; Ullrich K; Wendel U; Groenier KH; Smit GP
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S83-7. PubMed ID: 12373578
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil adherence receptor deficiency regressing with granulocyte-colony stimulating factor therapy in a case of glycogen storage disease type Ib.
Latger-Cannard V; Marchand-Arvier M; Vidailhet M; Donadieu J; Vigneron C; Bordigoni P
Eur J Pediatr; 2002 Feb; 161(2):87-93. PubMed ID: 11954758
[TBL] [Abstract][Full Text] [Related]
13. Glycogen storage disease type Ib neutrophils exhibit impaired cell adhesion and migration.
Kim GY; Lee YM; Kwon JH; Jun HS; Chou J
Biochem Biophys Res Commun; 2017 Jan; 482(4):569-574. PubMed ID: 27864142
[TBL] [Abstract][Full Text] [Related]
14. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I.
Visser G; Rake JP; Fernandes J; Labrune P; Leonard JV; Moses S; Ullrich K; Smit GP
J Pediatr; 2000 Aug; 137(2):187-91. PubMed ID: 10931410
[TBL] [Abstract][Full Text] [Related]
15. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
[TBL] [Abstract][Full Text] [Related]
16. Impact of genotype on neutropenia in a large cohort of Serbian patients with glycogen storage disease type Ib.
Sarajlija A; Djordjevic M; Kecman B; Skakic A; Pavlovic S; Pasic S; Stojiljkovic M
Eur J Med Genet; 2020 Mar; 63(3):103767. PubMed ID: 31536830
[TBL] [Abstract][Full Text] [Related]
17. Empagliflozin for treating neutropenia and neutrophil dysfunction in 21 infants with glycogen storage disease 1b.
Grünert SC; Gautschi M; Baker J; Boyer M; Burlina A; Casswall T; Corpeleijn W; Çıki K; Cotter M; Crushell E; Derks TGJ; Haas D; Kilavuz S; Kingma SDK; Korman SH; Kozek A; de Laet C; Mundy H; Nassogne MC; Quintero V; Rossi A; Spenger J; Spiegel R; Stephenne X; Stojkov D; Tal G; Veiga-da Cunha M; Wortmann SB
Mol Genet Metab; 2024 Jun; 142(2):108486. PubMed ID: 38733639
[TBL] [Abstract][Full Text] [Related]
18. Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib.
Grünert SC; Elling R; Maag B; Wortmann SB; Derks TGJ; Hannibal L; Schumann A; Rosenbaum-Fabian S; Spiekerkoetter U
Orphanet J Rare Dis; 2020 Aug; 15(1):218. PubMed ID: 32838757
[TBL] [Abstract][Full Text] [Related]
19. Survival, but not maturation, is affected in neutrophil progenitors from GSD-1b patients.
Visser G; de Jager W; Verhagen LP; Smit GP; Wijburg FA; Prakken BJ; Coffer PJ; Buitenhuis M
J Inherit Metab Dis; 2012 Mar; 35(2):287-300. PubMed ID: 21863279
[TBL] [Abstract][Full Text] [Related]
20. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.
Rosenberg PS; Alter BP; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Fier C; Freedman M; Kannourakis G; Kinsey S; Schwinzer B; Zeidler C; Welte K; Dale DC;
Blood; 2006 Jun; 107(12):4628-35. PubMed ID: 16497969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
